Clinical Trials Directory

Trials / Sponsors / Immunic AG

Immunic AG

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingStudy to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Scleros
Multiple Sclerosis, Relapsing-Remitting
Phase 32022-01-12
TerminatedIMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer
Metastatic Castration Resistant Prostate Cancer
Phase 12021-12-09
Active Not RecruitingStudy to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclero
Multiple Sclerosis
Phase 32021-11-18
Active Not RecruitingStudy to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosi
Multiple Sclerosis
Phase 22021-09-30
CompletedA Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of S
COVID-19
Phase 2 / Phase 32020-06-11
Active Not RecruitingMRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)
Relapsing-Remitting Multiple Sclerosis (RRMS)
Phase 22019-01-28
TerminatedPhase 2 Dose-finding IMU-838 for Ulcerative Colitis
Ulcerative Colitis
Phase 22018-03-15